Ziopharm Oncology
ZIOP
$0.87
Share price
-0.88%
Change (1 day)
-74.86%
Change (1 year)
Categories
Market capitalization of Ziopharm Oncology (ZIOP)
Market cap: $0.18 Billion
As of May 2024 Ziopharm Oncology has a market cap of $0.18 Billion. This makes Ziopharm Oncology the world's 7016th most valuable company by market cap according to our data. The market capitalization, commonly called market cap, is the total market value of a publicly traded company's outstanding shares and is commonly used to measure how much a company is worth.
Market cap history of Ziopharm Oncology from 2005 to 2022
End of year Market Cap
| Year | Market cap | Change |
|---|---|---|
| 2022 | $0.18 B | -20.58% |
| 2021 | $0.23 B | -56.37% |
| 2020 | $0.54 B | -37.07% |
| 2019 | $0.85 B | 184.9% |
| 2018 | $0.30 B | -48.75% |
| 2017 | $0.58 B | -16.61% |
| 2016 | $0.70 B | -35.61% |
| 2015 | $1.09 B | 106.69% |
| 2014 | $0.52 B | 21.83% |
| 2013 | $0.43 B | 25.54% |
| 2012 | $0.34 B | 14.71% |
| 2011 | $0.30 B | 33.66% |
| 2010 | $0.22 B | 83.49% |
| 2009 | $0.12 B | 892.89% |
| 2008 | $12.39 M | -83.56% |
| 2007 | $75.39 M | -17.31% |
| 2006 | $91.17 M | 287.07% |
| 2005 | $23.55 M |
Market capitalization for similar companies or competitors
| Name | Market cap | Market cap differencediff. | Country |
|---|---|---|---|
 Amgen AMGN | $160.34 B | 85,592.52% | 🇺🇸 USA |
 Baxter BAX | $18.41 B | 9,739.33% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | $89.02 B | 47,474.41% | 🇺🇸 USA |
 Cleveland BioLabs
CBLI | $49.06 M | -73.78% | 🇺🇸 USA |